Liu, Mingshan
Zhou, Ruihao
Zou, Wei
Yang, Zhuofan
Li, Quanjin
Chen, Zhiguo
jiang, Lei
Zhang, Jingtao
Article History
Received: 27 July 2022
Accepted: 27 June 2023
First Online: 7 September 2023
Declarations
:
: This study was approved by the Tumor Gene Atlas Project of the First Affiliated Hospital of Nanchang University and approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University on May 1, 2022 (Approval Number. 202203005). All study involving human experiments was informed written consent from all participants and in accordance with the Helsinki Declaration of Ethics Principles for Medical Research.
: In the qRT-PCR and immunohistochemistry experiments, the baseline information (such as age and sex) from lung cancer patients present in the study was obtained written informed consent before the study. Patient consent has also been obtained for the publication of this research paper.
: The authors declare that they have no competing interests.